Trevor Nolan

Trevor Nolan has an extensive work experience in finance and executive roles. Trevor is currently the Chief Financial Officer at Charnwood Molecular since February 2020. Prior to this, they served as the Finance Director at Source BioScience from January 2018 to February 2020. Trevor also worked as the Director of Finance at Fresenius Medical Care from September 2008 to December 2017. Before that, they were the Finance Manager at Nations Healthcare from January 2006 to September 2008. Additionally, they held the position of Finance Operations Manager at DOLLOND & AITCHISON LIMITED from April 2001 to December 2005. Trevor started their career as an Audit Executive at Ernst & Young, where they worked from September 1997 to April 2001. Most recently, they joined Aurelia Bioscience Ltd as a Director in June 2021. Overall, Trevor has a wealth of experience in finance and has held various leadership positions throughout their career.

Trevor Nolan completed their BSc in Chemistry at the University of Leicester from 1991 to 1994. Trevor then pursued a PhD in Chemistry at the University of Nottingham from 1994 to 1997.